Meg Dodge
Investor Relations Contact chez KRYSTAL BIOTECH, INC.
Profil
Meg Dodge is the founder of Indigo 8 Advisors LLC.
She currently holds the position of Head-Investors & Media at Krystal Biotech, Inc. Previously, she worked as SVP-Corporate Strategy & Investor Relations at Équilibre BioPharmaceuticals Corp.
and Graviton Bioscience Corp.
Ms. Dodge completed her undergraduate degree at Colby College and her graduate degree at New York University School of Law.
Postes actifs de Meg Dodge
| Sociétés | Poste | Début |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Investor Relations Contact | - |
Anciens postes connus de Meg Dodge
| Sociétés | Poste | Fin |
|---|---|---|
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Graviton Bioscience Corp. develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases. The company is based in New York, NY. The company was founded by Samuel D. Waksal. Samuel D. Waksal has been the CEO since incorporation. | Public Communications Contact | - |
| Indigo 8 Advisors LLC | Fondateur | - |
Équilibre BioPharmaceuticals Corp.
 Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Public Communications Contact | - |
Formation de Meg Dodge
| Colby College | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Équilibre BioPharmaceuticals Corp.
Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Health Technology |
Graviton Bioscience Corp.
Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Graviton Bioscience Corp. develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases. The company is based in New York, NY. The company was founded by Samuel D. Waksal. Samuel D. Waksal has been the CEO since incorporation. | Health Technology |
| Indigo 8 Advisors LLC |
